title: Role of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry.
abstract: Growth-restricted fetuses with absent or reversed end-diastolic velocities in the umbilical artery are at substantially increased risk for adverse perinatal and long-term outcome, even in comparison to growth-restricted fetuses with preserved end-diastolic velocities. Translational studies show that this Doppler velocimetry correlates with fetoplacental blood flow, with absent or reversed end-diastolic velocities signifying abnormally elevated resistance within the placental vasculature. The fetoplacental vasculature is unique in that it is not subject to autonomic regulation, unlike other vascular beds. Instead, humoral mediators, many of which are synthesized by local endothelial cells, regulate placental vascular resistance. Existing data demonstrate that in growth-restricted pregnancies complicated by absent or reversed umbilical artery end-diastolic velocities, an imbalance in production of these vasoactive substances occurs, favoring vasoconstriction. Morphologically, placentas from these pregnancies also demonstrate impaired angiogenesis, whereby vessels within the terminal villi are sparsely branched, abnormally thin, and elongated. This structural deviation from normal placental angiogenesis restricts blood flow and further contributes to elevated fetoplacental vascular resistance. Although considerable work has been done in the field of fetoplacental vascular development and function, much remains unknown about the mechanisms underlying impaired development and function of the human fetoplacental vasculature, especially in the context of severe fetal growth restriction with absent or reversed umbilical artery end-diastolic velocities. Fetoplacental endothelial cells are key regulators of angiogenesis and vasomotor tone. A thorough understanding of their role in placental vascular biology carries the significant potential of discovering clinically relevant and innovative approaches to prevention and treatment of fetal growth restriction with compromised umbilical artery end-diastolic velocities.
authors.affiliation: Department of Obstetrics and Gynecology, Divisions of Maternal-Fetal Medicine and Basic Reproductive Science, University of Colorado Denver School of Medicine, Aurora, CO. Electronic address: emily.su@ucdenver.edu.
authors.forename: Emily J
authors.initials: EJ
authors.lastname: Su
mesh_terms: D001783:Blood Flow Velocity / Q000502:physiology; D004730:Endothelium, Vascular / Q000503:physiopathology*; D005260:Female; D005317:Fetal Growth Retardation / Q000503:physiopathology*; D006801:Humans; D009389:Neovascularization, Pathologic / Q000473:pathology; D010920:Placenta / Q000098:blood supply / Q000473:pathology / Q000503:physiopathology*; D011247:Pregnancy; D018608:Ultrasonography, Doppler; D014469:Umbilical Arteries / Q000000981:diagnostic imaging / Q000503:physiopathology*
keywords: VGEF; VGEF receptor 2; absent end-diastolic velocity; angiogenesis; fetal growth restriction; fetoplacental endothelium; placental circulation; placental growth factor; umbilical artery Doppler